http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2272162-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_810c646681828edb1fd939803751e559
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-106
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-08
filingDate 2005-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2008-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31f816e244580dfb83eaa28f0a1bb201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8af188888947a1493aaf6d41be08fcd5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac2fc79c4e576e77589c21c789fe2ba1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6d8f7eb9a3ae997ddd1fba6325cd959
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ac33667ed79f5a9ba36afd8ccdc5615
publicationDate 2008-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2272162-B1
titleOfInvention DEVICE FOR THE CONTROLLED RELEASE OF PHARMACOS.
abstract Device for controlled release ofndrugsn n n Drug release method based onncoatings on medical devices consisting ofnnanostructured inorganic materials, such as zeolites, sievesnmesoporous molecules, titanosilicates, and micro- and nanocapsulesnhollow mesoporous silica. The coatings are constitutednby individual particles, or by films thereofnmaterials. The coatings are applied to surfaces usednin medicine (intravascular stents or other devices thatnthey are inserted in the appropriate place of the organism in order tonrelease therapeutic substances). Individual particles ornwell the films that constitute the coating are carriersnof a drug, stored in micro or mesopores of the material, or innlarger internal cavities, as is the case with the spheresnof mesoporous silica. The porosity and thickness of each material andncoating controls the speed of diffusion of the drug. Theninorganic materials can be modified by giving them propertiesnsuitable (for example, magnetism).
priorityDate 2005-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453035991
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501920
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419867934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758

Total number of triples: 29.